 |
|
Clinical Trial for Antidiabetic Drugs: FDA Guidance for Diabetes Mellitus-Evaluation of Cardiovascular Risk in New Antidiabetic Therapies.
Moonsuk Nam
J Korean Diabetes. 2011;12(3):129-132. Published online 2011 Sep 1 DOI: https://doi.org/10.4093/kcd.2011.12.3.129
|
|
Citations to this article as recorded by
 Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
A.K. Pancholia
Indian Heart Journal.2018; 70(6): 915. CrossRef
|